MARKET

CTKB

CTKB

Cytek Biosciences, Inc.
NASDAQ
3.680
-0.360
-8.91%
Pre Market: 3.550 -0.13 -3.53% 04:00 05/14 EDT
OPEN
4.010
PREV CLOSE
4.040
HIGH
4.020
LOW
3.645
VOLUME
2
TURNOVER
0
52 WEEK HIGH
6.18
52 WEEK LOW
2.370
MARKET CAP
475.24M
P/E (TTM)
-6.3734
1D
5D
1M
3M
1Y
5Y
1D
Cytek Biosciences Is Maintained at Overweight by Stephens & Co.
Dow Jones · 19h ago
Cytek Biosciences Price Target Cut to $4.75/Share From $5.50 by Stephens & Co.
Dow Jones · 19h ago
Stephens & Co. Maintains Overweight on Cytek Biosciences, Lowers Price Target to $4.75
Benzinga · 19h ago
Cytek Biosciences price target lowered to $4.75 from $5.50 at Stephens
TipRanks · 22h ago
Cytek Biosciences Price Target Cut to $5.50/Share From $6.00 by Morgan Stanley
Dow Jones · 1d ago
Cytek Biosciences Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 1d ago
Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $5.5
Benzinga · 1d ago
Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley
TipRanks · 1d ago
More
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Webull offers Cytek Biosciences Inc stock information, including NASDAQ: CTKB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTKB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTKB stock methods without spending real money on the virtual paper trading platform.